EFHC1 Polyclonal Antibody, Cy5.5 Conjugated, Rabbit

Artikelnummer: BSS-BS-9013R-CY5.5
Artikelname: EFHC1 Polyclonal Antibody, Cy5.5 Conjugated, Rabbit
Artikelnummer: BSS-BS-9013R-CY5.5
Hersteller Artikelnummer: bs-9013R-Cy5.5
Alternativnummer: BSS-BS-9013R-CY5.5-100
Hersteller: Bioss
Wirt: Rabbit
Kategorie: Antikörper
Applikation: IF
Spezies Reaktivität: Human, Mouse, Rat
Konjugation: Cy5.5
Alternative Synonym: EF hand domain C terminal containing 1, EF hand domain containing protein 1, EF-hand domain-containing protein 1, Efhc1, EFHC1_HUMAN, EJA1, EJM1, FLJ10466, FLJ37290, JAE, Myoclonin 1, Myoclonin-1.
Defects in EFHC1 are the cause of juvenile myoclonic epilepsy type 1 (EJM1) [MIM:254770]. EJM1 is a subtype of idiopathic generalized epilepsy (IGE). Patients have afebrile seizures only, with onset in adolescence (rather than in childhood) and myoclonic jerks which usually occur after awakening and are triggered by sleep deprivation and fatigue.Genetic variations in EFHC1 are the cause of susceptibility to juvenile absence epilepsy type 1 (JAE1) . JAE is a subtype of idiopathic generalized epilepsy characterized by onset occurring around puberty, absence seizures, generalized tonic-clonic seizures (GTCS), GTCS on awakening, and myoclonic seizures.
Klonalität: Polyclonal
Konzentration: 1ug/ul
NCBI: 114327
Puffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Quelle: KLH conjugated synthetic peptide derived from human EFHC1
Target-Kategorie: EFHC1
Application Verdünnung: IF(IF=1:50-200)